SEVERE HEMOPHILIA B
Clinical trials for SEVERE HEMOPHILIA B explained in plain language.
Never miss a new study
Get alerted when new SEVERE HEMOPHILIA B trials appear
Sign up with your email to follow new studies for SEVERE HEMOPHILIA B, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New shot could cut bleeds in kids with hemophilia
Disease control Recruiting nowThis phase 3 trial is testing a drug called fitusiran in about 85 boys aged 1 to under 12 with severe hemophilia A or B, including those with inhibitors that make standard treatments less effective. The drug is given as a regular shot under the skin to help prevent bleeding episo…
Matched conditions: SEVERE HEMOPHILIA B
Phase: PHASE3 • Sponsor: Sanofi • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
New blood test could improve bleeding control for hemophilia patients
Knowledge-focused Recruiting nowThis study aims to create a reliable lab test to monitor how well anti-TFPI antibodies work in people with severe hemophilia. Researchers will take a single blood sample from 11 patients already on anti-TFPI therapy and test it in the lab. The goal is to better predict and manage…
Matched conditions: SEVERE HEMOPHILIA B
Sponsor: Hospices Civils de Lyon • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC